Free Trial

Tissue Regenix Group (TRX) Competitors

GBX 54
0.00 (0.00%)
(As of 10/4/2024 ET)

TRX vs. NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, WPM, and IAG

Should you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), Wheaton Precious Metals (WPM), and International Consolidated Airlines Group (IAG). These companies are all part of the "precious metals" industry.

Tissue Regenix Group vs.

Nakama Group plc (NAK.L) (LON:NAK) and Tissue Regenix Group (LON:TRX) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

37.1% of Tissue Regenix Group shares are owned by institutional investors. 47.2% of Tissue Regenix Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Nakama Group plc (NAK.L)'s average media sentiment score of 0.00 equaled Tissue Regenix Group'saverage media sentiment score.

Company Overall Sentiment
Nakama Group plc (NAK.L) Neutral
Tissue Regenix Group Neutral

Nakama Group plc (NAK.L) has higher earnings, but lower revenue than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Nakama Group plc (NAK.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nakama Group plc (NAK.L)£8.09M0.18N/A-£0.20-6.13
Tissue Regenix Group£31.80M1.21-£1.10M-£0.01-5,400.00

Nakama Group plc (NAK.L) has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Nakama Group plc (NAK.L)'s return on equity of 0.00% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Nakama Group plc (NAK.L)N/A N/A N/A
Tissue Regenix Group -3.46%-3.31%0.50%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nakama Group plc (NAK.L)
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Tissue Regenix Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Nakama Group plc (NAK.L) received 61 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 90.28% of users gave Nakama Group plc (NAK.L) an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote.

CompanyUnderperformOutperform
Nakama Group plc (NAK.L)Outperform Votes
223
90.28%
Underperform Votes
24
9.72%
Tissue Regenix GroupOutperform Votes
162
69.53%
Underperform Votes
71
30.47%

Summary

Tissue Regenix Group beats Nakama Group plc (NAK.L) on 6 of the 11 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRX vs. The Competition

MetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON Exchange
Market Cap£38.46M£225.65M£5.56B£1.34B
Dividend Yield4.12%3.53%4.66%7.85%
P/E Ratio-5,400.00207.95121.721,597.90
Price / Sales1.2113,194.141,145.53190,157.51
Price / Cash5.7011.5739.3633.77
Price / Book1.268.054.912.48
Net Income-£1.10M-£25.24M£116.77M£151.24M
7 Day Performance-1.64%0.20%3.00%-0.09%
1 Month Performance-13.04%20.48%15.58%2.30%
1 Year Performance-5.26%24.50%25.88%18.77%

Tissue Regenix Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRX
Tissue Regenix Group
N/AGBX 54
flat
N/A-4.5%£38.46M£31.80M-5,400.00120High Trading Volume
NAK
Nakama Group plc (NAK.L)
N/AGBX 1.23
+6.5%
N/A+0.0%£1.44M£8.09M-6.1353Gap Down
High Trading Volume
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/A0.006Gap Down
High Trading Volume
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/A0.005,360High Trading Volume
EDG
651814 (EDG.L)
N/AN/AN/AN/A£0.00N/A0.002,610
MTA
ArcelorMittal
N/AN/AN/AN/A£0.00N/A0.009Negative News
High Trading Volume
NGR
Nature Group
N/AN/AN/AN/A£0.00N/A0.0010Gap Up
RRS
Randgold Resources
N/AGBX 6,546
+7,701,076.5%
N/AN/A£0.00N/A0.0021,300Gap Up
NG
National Grid
2.1601 of 5 stars
GBX 1,035
-0.2%
GBX 1,218.33
+17.7%
+8.7%£50.61B£19.85B1,881.8210Insider Buying
News Coverage
High Trading Volume
WPM
Wheaton Precious Metals
1.7524 of 5 stars
GBX 4,537.06
-3.9%
GBX 5,200
+14.6%
+44.9%£20.58B£1.13B4,826.6640Positive News
Gap Down
IAG
International Consolidated Airlines Group
2.6813 of 5 stars
GBX 206.10
-2.9%
GBX 225
+9.2%
+26.9%£10.10B£30.59B490.715,360High Trading Volume

Related Companies and Tools


This page (LON:TRX) was last updated on 10/5/2024 by MarketBeat.com Staff
From Our Partners